NDC11 64980069701
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 64980-0697-01 | 64980-0697 |
| 64980-0697-1 | 64980-0697 |
| 64980-697-01 | 64980-697 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| GLIPIZIDE | GLIPIZIDE | Rising Pharma Holdings, Inc. | 82a5ea4b-4d1d-41e9-bb44-29c54d333411 | 2026-04-24 | Warnings, Adverse reactions | 64980-697-01 64980-697 64980069701 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.